Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus
RG7834 is a small‐molecule inhibitor of hepatitis B virus (HBV) gene expression that significantly reduces the levels of hepatitis B surface antigen (HBsAg) and HBV DNA in a humanized liver HBV mouse model. In the current study, we evaluated the potency of RG7834 in the woodchuck model of chronic HB...
Main Authors: | Stephan Menne, Steffen Wildum, Guido Steiner, Manasa Suresh, Kyle Korolowicz, Maria Balarezo, Changsuek Yon, Marta Murreddu, Xupeng Hong, Bhaskar V. Kallakury, Robin Tucker, Song Yang, John A.T. Young, Hassan Javanbakht |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2020-06-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1502 |
Similar Items
-
Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B
by: Kyle E. Korolowicz, et al.
Published: (2021-04-01) -
Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks.
by: Manasa Suresh, et al.
Published: (2017-01-01) -
Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B
by: Steffen Wildum, et al.
Published: (2022-05-01) -
Liver‐Targeted Toll‐Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus
by: Kyle E. Korolowizc, et al.
Published: (2019-10-01) -
Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B
by: Manasa Suresh, et al.
Published: (2022-08-01)